XTalks

FEBRUARY 5, 2025

The approval marks Celltrions seventh biosimilar to be granted marketing authorization in the US and its fifth immunology biologic approval. The approval encompasses both intravenous (IV) and subcutaneous (SC) formulations, offering flexibility in administration.

FDA Approval 102

FDA Approval Marketing Antibody Immune Response 102

Drug Patent Watch

JANUARY 13, 2025

As we delve into the intricate world of biosimilar market dynamics, we’ll explore how these complex molecules are reshaping treatment paradigms across diverse patient populations. ”[1] The global biosimilars market is experiencing exponential growth, with projections indicating it will reach $69.4 from 2020 to 2025[1].

Marketing 61

Marketing Insulin Generic Drugs Medicine 61

Intouch Solutions

DECEMBER 2, 2024

In the rapidly evolving landscape of direct-to-consumer (DTC) marketing, artificial intelligence (AI) is emerging as a transformative force. For large pharmaceutical companies and their senior brand marketers, understanding and leveraging AI can significantly enhance the effectiveness and efficiency of their marketing strategies.

Marketing 59

Marketing Branding Pharma Companies Development 59

Bio Pharma Dive

JUNE 18, 2025

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.

FDA Approval 285

FDA Approval Medicine Drugs Marketing 285

Pharma Marketing Network

MARCH 26, 2025

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.

Compliance 64

Compliance Marketing Regulation Pharma Companies 64

World of DTC Marketing

JUNE 27, 2025

appeared first on World of DTC Marketing. Instead, they prefer trusted, distilled information from accessible, authoritative sources tailored to their clinical needs and interests. Facebook Twitter LinkedIn Tumblr Bluesky Email Reddit WhatsApp The post Do Physicians Want Updates On Clinical Trial?

Clinical Trials 246

Clinical Trials Clinical Trials Trials Sales 246

Intouch Solutions

JANUARY 17, 2025

In a recent article published by Med Ad News , Mary Anderson, Senior VP, Managing Director and Head of MedComm at EVERSANA INTOUCH, highlighted the pivotal role medical communications (MedComm) has played in giving brands a leg up in a competitive market.

Marketing 59

Marketing Branding Trials 59

World of DTC Marketing

JUNE 6, 2025

Bringing this ethos into the corporate setting can enrich company culture and help bridge internal silos between marketing, R&D, and compliance. Concepts such as market access, payer dynamics, product positioning, and ROI may be unfamiliar territory. appeared first on World of DTC Marketing. Where the Gaps Often Lie 1.

Compliance 244

Compliance Marketing Life Science Production 244

Drug Patent Watch

FEBRUARY 5, 2025

The Latin American Pharmaceutical Market: Why Specialty Generics Are Poised for Growth As the pharmaceutical industry continues to evolve, one trend is becoming increasingly clear: the demand for specialty generics is on the rise, particularly in the Latin American market. What do you think is the future of the pharmaceutical industry?

Marketing 82

Marketing Manufacturing Development 82

World of DTC Marketing

JUNE 25, 2025

Equally crucial is having the strategic leadership to effectively commercialize innovations and transform scientific potential into market reality. Enter the Chief Commercial Officer (CCO)—a role that goes beyond just sales and marketing. Proven familiarity with FDA regulations, compliance issues, and market access strategies.

Regulation 166

Regulation Marketing Compliance Sales 166

World of DTC Marketing

JUNE 26, 2025

In biotech and pharma, a strong Vice President (VP) of Medical Affairs can significantly impact a company’s path to clinical success and market credibility. What to look for: Real-world experience in both research and patient care, plus a history of strategic decision-making in late-stage development or post-market environments.

Marketing 171

Marketing Compliance Clinical Trials Clinical Trials 171

World of DTC Marketing

JUNE 3, 2025

After all, Medical Affairs serves as the bridge between clinical research, regulatory compliance, marketing, and real-world evidence — all areas where deep medical knowledge is a valuable asset. In the pharma industry, it’s almost reflexive to tap an MD for the role of Vice President of Medical Affairs. The result?

Compliance 194

Compliance Doctors Doctor Marketing 194

Pharma Marketing Network

APRIL 10, 2025

In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Strategic Audience Targeting and Keyword Planning One of the key advantages of PPC campaigns in pharma marketing is their precision.

Marketing 52

Marketing Branding Compliance Pharma Companies 52

Pharmaceutical Commerce

JULY 9, 2025

reacts to the challenge of launching orphan drugs without complete evidence, particularly given their high cost and limited patient populations, and suggests strategies that can be used to address evidence gaps, enable market access, and support long-term patient benefit. Edward Ahn, CEO of MEDIPOST, Inc.,

Marketing 52

Marketing Drugs 52

World of DTC Marketing

JUNE 19, 2025

They’re not wrong about the consequences, but they’re also ignoring a core reality: DTC marketing isn’t going anywhere in the U.S. That’s not just marketing money; it’s oxygen for media companies. But by then, the marketing campaign has run its course, and sales targets have been hit. anytime soon.

Doctors 254

Doctors Doctor Regulation Marketing 254

Pharmaceutical Commerce

JUNE 25, 2025

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based endpoints to ensure successful access, pricing, and long-term market viability—especially in a more complex, globally integrated reimbursement landscape.

Marketing 52

Marketing 52

World of DTC Marketing

JULY 19, 2025

Me-too drugs are therapeutics structurally similar or identical in mechanism to existing drugs already approved and marketed. After all, the pathway is clearer, clinical trials are predictable, and the market is somewhat guaranteed. The result is often pricing pressures, reduced market access, and disappointing sales.

Development 147

Development Drugs Clinical Trials Clinical Trials 147

Pharma Marketing Network

MAY 23, 2025

With the rising pressure to deliver compliant, engaging, and scalable campaigns, pharma marketers are turning to AI tools to streamline content creation, refine HCP targeting, and stay ahead of digital innovation. Moreover, with commercial teams stretched thin, AI helps marketers respond faster to HCP needs and behavior.

Compliance 64

Compliance Marketing Branding Pharma Companies 64

STAT News

JULY 11, 2025

The Food and Drug Administration rejected a marketing application from Capricor Therapeutics for a cell therapy to treat Duchenne muscular dystrophy, the company said Friday.    Capricor submitted a marketing application to the FDA at the end of December.

Gene Therapy 118

Gene Therapy Gene Marketing Drugs 118

Pharma Marketing Network

JUNE 3, 2025

For pharma marketers navigating strict compliance standards and shifting patient behavior, CTAs are not just marketing toolsthey are essential strategic assets. Today, digital-first strategies dominate, emphasizing email marketing, display ads, social media, webinars, and branded content.

Marketing 59

Marketing Branding Compliance Regulation 59

Drug Patent Watch

JANUARY 15, 2025

Business Strategists Business strategists use patent data to inform market entry strategies and competitive analysis. The shortcomings of Google Patents may lead to misinformed decisions due to incomplete market insights. Incomplete or outdated data from Google Patents can impact their ability to provide accurate legal counsel.

Drugs 53

Drugs Scientist Engineer Research 53

World of DTC Marketing

JULY 13, 2025

Long-winded explanations, clinical jargon, and “marketing speak” won’t land. Adapt to new market research and patient insights. They need to understand your DTC efforts, hear what market research is uncovering, and be informed about any shifts in strategy. Your website isn’t a side project—it’s a core marketing asset.

Production 157

Production Branding Marketing Doctors 157

Pharma Marketing Network

MAY 22, 2025

For decades, pharmaceutical marketing has relied on traditional playbookssegmentation models, field rep cadence, and linear messaging. But in 2025, the AI is Changing Pharma Marketing. AI changing pharma marketing isnt just about automation. AI and Omnichannel: Tying It All Together Omnichannel marketing was once aspirational.

Branding 52

Branding Marketing Compliance Engineer 52

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. In this post, we'll explore effective strategies for maximizing patent protection and exclusivity, ensuring your product remains a leader in the market.

Marketing 53

Marketing Drugs Production Sales 53

World of DTC Marketing

JUNE 9, 2025

But in a world where ROI is under scrutiny and consumer trust is a critical currency, pharma marketers need to ask: Is this the best use of our budget? The days of relying on a 60-second TV spot to create market demand are fading fast. Rethinking the Spend It’s no secret that DTC TV advertising costs millions.

Doctors 206

Doctors Doctor Drugs Marketing 206

World of DTC Marketing

JUNE 8, 2025

Direct-to-consumer (DTC) pharma marketing once burst onto the scene with bold creativity, powerful storytelling, and game-changing blockbuster drugs. So, what happened to those visionary marketers, and why has pharma advertising become so bland? These marketing pioneers didn’t just list symptoms and benefits.

Compliance 157

Compliance Marketing Branding Pharma Companies 157

Scienmag

JULY 4, 2025

Market pressure and organizational support emerged as potent influencers at the symbolic level, underscoring how institutional endorsement and competitive dynamics motivate clinicians to initially adopt CEUS. Such progression is not automatic; it hinges on a confluence of external and internal stimuli within the healthcare ecosystem.

Research 59

Research Marketing Regulation Development 59

World of DTC Marketing

JUNE 20, 2025

Pharmaceutical companies rely on predictable FDA actions—such as reviews, approvals, communications, and regulatory guidance—to plan product launches, clinical trials, and marketing strategies. Pharmaceutical companies should expect more rigorous inspections and higher thresholds for approval, as well as stricter post-marketing requirements.

Compliance 157

Compliance Pharma Companies Marketing Regulation 157

Drug Patent Watch

APRIL 8, 2025

Evaluate the number of products in development, their potential market size, and the competition. Market Trends : Stay up-to-date on market trends, including the shift towards personalized medicine and the growing importance of digital health.

Pharma Companies 74

Pharma Companies Generic Drugs Production Marketing 74

XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat.

Marketing 52

Marketing Branding Compliance Drugs 52

XTalks

JANUARY 2, 2025

(ATGC) has gone public with its initial public offering (IPO), marking a significant milestone in its journey to transform the heart valve market. Trading began on the Nasdaq Global Market on December 13, 2024, under the ticker symbol “AVR,” with the offering closed on December 16, 2024. The company offered 14.8

FDA Approval 110

FDA Approval Marketing Clinical Trials Clinical Trials 110

World of DTC Marketing

JULY 14, 2025

Today, it is shaped by regulatory scrutiny, digital disruption, data-driven marketing, and increasing skepticism from both doctors and patients. Non-Personal Promotion (NPP) NPP campaigns that use programmatic ads, email marketing, and social media targeting can reach physicians at scale.

Regulation 157

Regulation Doctors Doctor Pharma Companies 157

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. New Drug Application (NDA) : Needed for marketing approval of new drugs.

Generic Drugs 52

Generic Drugs Bioequivalency Development Drugs 52

Scienmag

JUNE 30, 2025

However, the journey from promising laboratory discovery to market-ready biomedical product still faces formidable hurdles. These factors collectively contribute to the protracted timeline and elevated costs associated with bringing renewable polymer-based biomaterials to market.

Medicine 87

Medicine Drug Delivery Systems Drug Delivery Engineer 87

STAT News

JUNE 30, 2025

The biotechnology company Mirvie is leading the charge, with its second trimester test already on the market. Efforts to develop blood tests for preeclampsia, which causes high blood pressure and organ damage in pregnant individuals, are ongoing.

Marketing 83

Marketing Research Development 83

STAT News

JUNE 30, 2025

ASPEN, Colo. — When Jessica Owens was toiling away in graduate school, she didn’t know what a venture capitalist was, much less that she’d one day launch her own firm and raise its inaugural $45 million fund. program before she ditched the lab to explore the world of finance.

Life Science 66

Life Science Gene Sequencing Marketing Gene 66